Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone vs Placebo vs Haloperidol as Add-on in Bipolar Mania
NCT00253149Phase 3Completed
- Sponsor
- Johnson & Johnson
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in bipolar disorder (BD), sponsored by Johnson & Johnson. Status: completed.
02
Drugs
risperidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00253149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253149.